Context Therapeutics Inc. (CNTX)

AI Score

Unlock

0.91

0.08 (9.11%)

At close: Apr 22, 2025, 3:59 PM

0.94

3.43%

After-hours: Apr 22, 2025, 05:38 PM EDT

Context Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-3.34M	-17.46M	-2.25M	-3.67M	-6.77M	-5.87M	-5.01M	-6.31M	-3.56M	-3.85M	-3.99M	-3.44M	-3.09M	-1.44M	-5.03M	-892.05K	-784.75K	-876.24K	7.48M	826.48K
Depreciation & Amortization	2.93K	2.81K	2.57K	2.57K	2.57K	3.09K	3.19K	3.19K	3.19K	3.19K	2.88K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	231.82K	213K	157.04K	240.01K	256.05K	254.95K	283.1K	282.76K	243.64K	276.52K	241.32K	214.96K	204.38K	161.82K	119.36K	25.51K	30.82K	30.82K	30.64K	126.97K
Other Working Capital	-2.23M	82.46K	217.63K	-597.75K	-1.27M	1.51M	90.95K	-273.93K	-82.84K	-490.53K	425.28K	658.47K	-1.37M	-764.88K	378.47K	396.72K	362.69K	285.47K	169.61K	-55.73K
Other Non-Cash Items	25.32K	14.77M	1.64M	582.79K	-294.02K	7.52K	22.37K	22.07K	21.79K	21.5K	521.22K	14.02K	-18.24K	-124.32K	3.46M	53.67K	15.21K	225.18K	-8.13M	-1.33M
Deferred Income Tax	n/a	n/a	n/a	n/a	294.02K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.82M	544.25K	-1.26M	-935.4K	-715.9K	2.15M	71.55K	271.83K	-641.51K	559K	415.91K	-610.92K	-2.06M	1.36M	-628.15K	-902.38K	562.7K	270.04K	299.92K	185.65K
Operating Cash Flow	-4.91M	-1.93M	-3.36M	-4.36M	-7.23M	-3.46M	-4.63M	-5.73M	-3.93M	-2.99M	-2.81M	-3.82M	-4.96M	-43.63K	-2.08M	-1.72M	-176.03K	-350.2K	-321.04K	-187.35K
Capital Expenditures	n/a	-7.32K	4.00	n/a	n/a	n/a	n/a	n/a	n/a	-500K	-1.84K	-35K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-14.75M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-500K	n/a	n/a	-250K	n/a	-250K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	-14.76M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-500K	-1.84K	-35K	-250K	n/a	-250K	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	124.05K	25K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	94.8M	n/a	n/a	n/a	n/a	n/a	n/a	-102.07K	n/a	-102.07K	54.23M	-816.92K	n/a	n/a	n/a	n/a	200K	n/a
Financial Cash Flow	14.54M	-44.63K	94.8M	n/a	n/a	n/a	n/a	n/a	n/a	-102.07K	n/a	-102.07K	54.23M	-816.92K	1.95M	3.03M	350K	450K	324.05K	25K
Net Cash Flow	9.63M	-16.74M	91.45M	-4.36M	-7.23M	-3.46M	-4.63M	-5.73M	-3.93M	-3.49M	-2.81M	-3.96M	49.27M	-860.55K	-380.61K	1.32M	173.97K	99.8K	3.02K	-162.35K
Free Cash Flow	-4.91M	7.71M	-3.36M	-4.36M	-7.23M	-3.46M	-4.63M	-5.73M	-3.93M	-3.49M	-2.81M	-3.86M	-4.96M	-43.63K	-2.08M	-1.72M	-176.03K	-350.2K	-321.04K	-187.35K